Brad Walsh

Latest articles

4d
Business Wire
Minomic Launches US Prospective Study of MiCheck® Prostate Cancer TestTest via Clinical Laboratory Improvements Amendment (CLIA) Act certified labora
Business Wire / Posted 4 days ago
Test via Clinical Laboratory Improvements Amendment (CLIA) Act certified laboratories,” Minomic Chief Executive Officer, Dr Brad Walsh, explained. “The data will also be used to support our overall commercialization strategy.” “This trial with CUSP... Read more
23d
Business Wire
Minomic Clinical Study Progresses For MiltuximabTM In Prostate, Bladder, and Pancreatic Cancercells, and is well-tolerated and highly specific in mouse models of prostate ca
Business Wire / Posted 23 days ago
cells, and is well-tolerated and highly specific in mouse models of prostate cancer. Minomic’s Chief Executive Officer, Dr Brad Walsh, said, “The results from this trial are providing us with important safety data as well as telling us how well the... Read more

In this news